<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>Humantrials on Tenu Tech Brief</title>
    <link>https://cluster-site.onrender.com/tags/humantrials/</link>
    <description>Recent content in Humantrials on Tenu Tech Brief</description>
    <generator>Hugo -- 0.146.0</generator>
    <language>en-us</language>
    <lastBuildDate>Tue, 24 Feb 2026 06:04:12 +0000</lastBuildDate>
    <atom:link href="https://cluster-site.onrender.com/tags/humantrials/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>China brain computer interface outfit accelerates to human trials in quest to outpace Neuralink - mix of government backing and investor enthusiasm speeds time to market for NeuroXess</title>
      <link>https://cluster-site.onrender.com/posts/china-brain-computer-interface-outfit-accelerates-to-human-trials-in-quest-to-outpace-neuralink-mix-of-government-backing-and-investor-enthusiasm-speeds-time-to-market-for-neuroxess/</link>
      <pubDate>Thu, 19 Feb 2026 11:00:00 +0000</pubDate>
      <guid>https://cluster-site.onrender.com/posts/china-brain-computer-interface-outfit-accelerates-to-human-trials-in-quest-to-outpace-neuralink-mix-of-government-backing-and-investor-enthusiasm-speeds-time-to-market-for-neuroxess/</guid>
      <description>• China&amp;rsquo;s NeuroXess accelerates to human trials, aiming to outpace Neuralink. • Founded in 2021, the Shanghai-based firm reports successful invasive BCI trials. • A paralyzed patie</description>
    </item>
  </channel>
</rss>
